No permission for SII to conduct trial on kids
An expert panel of the country's central drug authority on Wednesday recommended against granting permission to the Serum Institute of India (SII) to conduct the phase 2/3 trial of Covid-19 vaccine Covovax on children aged two to 17 years, sources said.
from Times of India https://ift.tt/3yefZ1M
via IFTTT
from Times of India https://ift.tt/3yefZ1M
via IFTTT
Comments
Post a Comment